Creating an electronic registry for patients with advanced heart failure and heart transplantation
Electronic Register on Advanced Heart Failure and Transplantation
This study is trying to create an electronic record system to track patients with advanced heart failure and heart transplants to better understand their health and hospital visits.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna Academic / other |
| Locations | 1 site (Bologna) |
| Trial ID | NCT06773611 on ClinicalTrials.gov |
What this trial studies
This observational study aims to establish an electronic registry for patients diagnosed with advanced heart failure or those who have undergone heart transplantation, dating back to January 1, 1985. The study will assess the incidence of these conditions and characterize the patient population affected by them. It will focus on primary outcomes such as hospitalizations due to cardiovascular causes and mortality rates. The study employs both retrospective and prospective methodologies to gather comprehensive data on patient experiences and treatment outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older diagnosed with advanced heart failure or who have received a heart transplant.
Not a fit: Patients who do not have a diagnosis of advanced heart failure or have not undergone heart transplantation may not benefit from this study.
Why it matters
Potential benefit: If successful, this registry could enhance understanding of advanced heart failure and transplantation, leading to improved patient management and outcomes.
How similar studies have performed: Other studies have successfully utilized electronic registries to improve patient outcomes in heart failure and transplantation, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years * Ability to provide informed consent * Diagnosis of Advanced Heart Failure or Heart Transplant Exclusion Criteria: * none
Where this trial is running
Bologna
- IRCCS Azienda Ospedaliero-Universitaria di Bologna — Bologna, Italy (Recruiting)
Study contacts
- Principal investigator: Luciano G Potena, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Study coordinator: Luciano Potena, MD
- Email: scompenso.trapiantocuore@aosp.bo.it
- Phone: 051-2143725
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.